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Abstract
Background
A noninvasive method to predict the grade of a meningioma would be desirable since it would anticipate
information about tumour nature, recurrence and improve tumour management and outcomes. The aim of the
present study was to assess the ability of perfusion computed tomography (PCT) technique in predicting the
meningioma grade before surgery. Data from PCT, such as cerebral blood volume (CBV) and permeability
surface (PS), were correlated with immunohistolopathological information.
Methods
Twenty-three patients with a diagnosis of intracranial meningioma underwent PCT for pre-surgical evaluation of
CBV and PS. During surgery, samples from the centre and periphery of the tumour were obtained. Two
correspondent regions of interest (ROIs) were drawn on CBV and PS maps. Central and peripheral CBV and PS
mean values were calculated. PCT parameters were correlated to CD-34 and endoglin.
Results
There was a positive correlation between PS and CD-34. No correlation was found between PS values and
endoglin, CBV values and CD-34 and endoglin values.
Conclusion
Our findings suggest that PCT may support conventional morphological imaging in predicting meningioma
grading before surgery.
Keywords: Meningioma, perfusion computed tomography, neoangiogenesis, CD-34, endoglin, permeability
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Introduction
Meningioma is one of the most common kinds of intracranial tumour,  representing 34% of all the intracranial
neoplasms.
Most of meningiomas are benign and originate from non-neuroepithelial progenitor cells, the arachnoidal cap
cells. As a subgroup of arachnoidal cells, the arachnoidal cap cells form the outer layer of the arachnoid mater
and the arachnoid villi. They are also involved in the resorption of cerebrospinal fluid into the dural sinuses and
veins.
According to the World Health Organization (WHO) 2007 classification system, meningiomas are classified into
three grades: Grade I meningiomas are benign and slow growing tumours; Grade II (atypical) and Grade III
(anaplastic) meningiomas are histologically aggressive.  The grading has implications on management and
prognosis because of atypical and anaplastic meningiomas often recur and have a poorer prognosis compared
with grade I tumours.
There is no specific neuroradiological pattern on traditional computed tomography (CT) scan neither on magnetic
resonance imaging (MRI) that allows meningioma grading to be established, unless necrosis or haemorrhage
areas are detected.  Advanced imaging techniques such as perfusion MRI or perfusion computed tomography
(PCT) can provide useful information about meningiomas grading, because of perfusion parameters indirectly
reflect the microvessel density (MVD) of the tumours.
Perfusion studies are obtained by monitoring the first passage of an iodinated contrast agent bolus through the
brain vessels. The distribution of the contrast medium following injection is determined by the
microvascularization and the diffusion across the endothelial membrane.
Regional cerebral blood volume (rCBV) reflects an assessment of tumour vasculature and perfusion and it can be
considered as a good surrogate marker for MVD, revealing information about the total amount of vessels in the
tumour including neovessels and the native vasculature. Permeability surface-area (PS) product indicates the
diffusion of contrast agent moving from the blood vessels into the interstitial space caused by tumour-induced
blood-brain barrier (BBB) disruption. Therefore, PS value is a valid in vivo measurement of the abnormal
tumour-vessels permeability with the strongest correlation with the tumour grade.
The aim of the present study was to assess the use of PCT technique in predicting the meningioma grade before
surgery, by evaluating the correlation between CBV and PS with CD-34 and endoglin,  immunoistochemical
markers of neoangiogenesis in meningiomas.
Materials and methods
Study population
From January 2013–November 2013 we prospectively evaluated 23 patients with a neuroradiological diagnosis
of intracranial meningioma. The entire study has been approved by the University Ethics Committee before
patient recruitment; written informed consent of all patients was obtained.
They were 7 males and 16 females, from 40–81 years old with a mean age of 60.2 (±11.1) years. Most of the
tumours were supratentorial. Some of the lesions showed few or scattered calcifications (Table 1). All patients
underwent PCT for pre-surgical evaluation of tumour blood volume and PS product. Patients underwent surgical
treatment and specimens from the centre and the periphery of the tumour were collected for histopathological
analysis.
Table 1.
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Evaluation of meningioma characteristic in each patient.
PCT technique and image processing
CT examination was performed by 64 multi-row CT scanner (Somatom Definition 64 Siemens, Erlangen,
Germany). A baseline non-contrast CT head study was done to localize the tumour, before obtaining a perfusion
scan. For the perfusion scan, 50 ml volume of a non-ionic contrast agent (Visipaque-320) was injected at a rate of
5 ml/s by using an automatic power injector through an 18-gauge intravenous line of an antecubital vein. Five
seconds following the injection, a continuous scanning was initiated and, from the selected axial section, 80
consecutive images were acquired with a time interval of 1 s. PCT parameters were: 80 kV, 180 mA, 512 × 512
matrix, field of view 20–25 cm, 4 × 5 mm sections with 10 mm-thick sections reformatting. The duration of the
total data acquisition was of 80 s.
All patients tolerated PCT well and showed no adverse reaction to the rapid bolus injection of contrast.
Perfusion CBV (ml/100 g) and PS (ml/100 g/min) maps and maximum intensity projection (MIP) images were
generated in a workstation, based on unidirectional two-compartment Patlak method, by using a post-processing
commercial software package (Volume Perfusion CT, Siemens, Erlangen, Germany). We also calculated cerebral
blood flow (CBF), time to start (TTS), time to peak (TTP), mean transit time (MTT) and time to drain
(TTD).  In all patients we used the superior sagittal sinus as the venous output function and the artery with
the greatest peak and slope on time-attenuation curves as the arterial input function.  The shape of the
arterial input function was automatically generated from branches of middle cerebral artery (MCA) and anterior
cerebral artery (ACA), the peak of the input function was normalized to the peak of the superior sagittal sinus.
Image analysis
Two regions of interest (ROIs) were drawn on the colorimetric perfusion maps for each patient. ROIs were
initially placed on the MIP images: the first ROI delimiting the central portion of the tumour, the second, a free-
hand ROI, delimiting the periphery of the neoplastic lesion (Figure 1). The ROIs were then automatically copied
onto the perfusion maps. Corresponding CBV and PS middle and standard deviation values of the central and the
peripheral portions of the meningioma were calculated.
Figure 1.
Regions of interest (ROIs) positioning in a 67-year-old female with a right
parafalcine meningioma.
Histopathological examination
At surgery, a peripheral and a central specimen were taken from 15 tumours. Only one specimen for each tumour
was obtained in eight cases. Samples were formalin fixed and paraffin embedded for the histological examination
and immunohistochemistry. In detail, from each paraffin block, serial 4 µm tissue sections were cut and stained
with conventional haematoxylin and eosin stain or processed for immunohistochemical procedures involving the
endothelial marker CD-34 and the specific marker for neoangiogenesis endoglin. Sections were successively
incubated with the primary monoclonal antibodies against endoglin (DAKO Corporation, Denmark, clone SN6h,
w.d. 1:50) and CD-34 (DAKO Corporation, Denmark, clone QBEnd10, w.d. 1:50). The bound primary antibodies
were visualized by LSAB kit (Dako Cytomation, Glostrup, Denmark) according to the manufacturer’s
instructions.
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As previously described, the quantification of microvessel was performed.  Briefly, the three most
vascularized areas detected by endoglin or CD-34 were initially selected (so-called hot spots) under 40× field.
Microvessels were counted in each of these areas under a 400× field. Single endothelial cells or cluster of
endothelial cells, with or without a lumen, were considered to be individual vessels. The mean value of three
400× field (0.30 mm ) counts was recorded as the MVD of the section. The MVD value was converted into the
mean number of microvessels/mm  for the statistical analysis.
Using a Zeiss microscope the vessels were counted by two observers, independent and blinded for the CT
perfusion data.
Statistical analysis
Statistical analysis was performed using SPSS statistical software package (version 19; SPSS, Inc., Chicago,
Illinois, USA). To test whether CBV and PS were able to predict meningioma grade, we correlated values
sampled both in central as well as in peripheral regions to CD-34 and endoglin histochemical markers obtained
from the same regions. To this end, we evaluated and tested, for each pair, Pearson’s coefficient (PCC); this
analysis was possible because all variables were normally distributed according to Shapiro-Wilk test (results not
shown). Values of p smaller than 0.05 were considered statistically significant; multiple comparison issue was
accounted for by means of Bonferroni correction.
Results
Data from 21 out of 23 patients were eligible for statistical analysis; one case (patient no. 18) was excluded
because that subject presented a calcified meningioma for which we could not measure CBV and PS; another one
(patient no. 5) was excluded because the subject has an angioblastic meningioma (CBV values obtained were
significantly higher compared with those presented in other patients).
CBV and PS mean and standard deviation values were calculated drawing ROIs in the solid part in patient no.
19, who showed a meningioma with some cystic central components. Eventually, in two patients (patient nos 2
and 4), who had partially calcified meningiomas, we obtained only a single ROI.
In eight patients it was not possible to evaluate peripheral values for CD-34 and endoglin. Hence, a total of 21
samples were used in analyses related to central regions, whereas for peripheral areas we used 13 left samples. In
our study there was a positive correlation between PS and CD-34 central values (PCC = 0.577, p = 0.0062
uncorrected, n = 21, R = .333) (Figure 2); on the other hand, no statistically significant correlation was found
between PS and CD-34 peripheral samplings (PCC = 0.287, p = 0.341 uncorrected, n = 13). Moreover, no
correlation was found between PS values and endoglin values, neither in central samples (PCC = 0.380, p = 0.090
uncorrected, n = 21) nor in peripheral samples (PCC = 0.572, p = 0.041 uncorrected, n = 13). No significant
correlations were found between CBV values and CD-34 and endoglin values, neither considering central
samples (PCC = 0.365, p = 0.103 uncorrected, n = 21 and PCC = 0.254, p = 0.267 uncorrected, n = 21
respectively), nor considering peripheral samples (PCC = 0.416, p = 0.157 uncorrected, n = 13 and PCC = 0.621,
p = 0.023 uncorrected, n = 13 respectively).
Figure 2.
Scatterplot of CD-34 and permeability surface-area (PS) product values
sampled from regions of interest (ROIs) segmenting central parts of 21
meningiomas; regression line is displayed as well (R = 0.333).
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Our study showed a significant statistically correlation between PS, a PCT parameter, and CD-34, an
immunohistochemical marker of neoangiogenesis in meningioma.
Compared with a MR perfusion study, PCT is a fast and low cost examination. The technique provides high
spatial resolution and it represents a valid alternative for the assessment of cerebral haemodynamics.
PCT is performed by monitoring the first passage of an iodinated contrast agent bolus through the brain vessels.
Conceptually, the contrast-medium pharmacokinetic involves three brain compartments: intracellular,
intravascular and interstitial. The iodinate molecules of the contrast-medium do not cross the cellular membrane
and do not reflow from the extravascular into the intravascular space. Therefore, for the evaluation of the
enhancement, the intracellular space can be ignored and just the unidirectional tracer distribution, into the two
remaining compartments (intravascular to interstitial), should be considered.
PCT provides a linear relation between density changes and tissue concentration of the contrast agent such as to
make reliable the quantification of PCT parameters. CBV is defined as the total volume of blood in a given
region of the brain and it is calculated as units of ml of blood per 100 g of brain tissue (ml/100 g). The CBV maps
are obtained from the mathematic integration of the area under the concentration versus time curve. CBV is a
good surrogate marker for MVD, revealing information about the amount of total vessels (neovessels and native
vasculature), but not of active endothelial cells proliferation.
PS characterizes the diffusion of the contrast agent from the neoangiogenic blood vessels into the interstitial
space due to tumour-induced BBB disruption and, therefore, it has a strongest correlation with the tumour
grade.
In the literature, previous data show the usefulness of PCT for the assessment of intra-axial tumour vascularity.
Malignant tumours are associated with increased angiogenic activity and neovascularization, resulting in
increased blood volume and hyperpermeability related to the presence of immature vessels. Increased vascular
permeability is also correlated with malignancy. It evolves as a surrogate marker of tumour angiogenesis and
tumour.  Higher permeability is associated with higher tumour grade and it can be considered as an
histologically pattern of blood-brain barrier disturbance.
Several lines of evidence support a good correlation between PCT parameters and histological markers of
angiogenesis, such as MVD, in gliomas with a resulting role of PCT in the assessment of neoplastic
grading.  For extra-axial tumours it has been demonstrated the correlation between PCT
parameters (i.e. CBV and PS) and MVD thus suggesting a possible role of PCT imaging in anticipating the
diagnosis between benign meningiomas and haemangiopericytomas.
In our study we observed some different PCT patterns of CBV and PS parameters with a different vessel
distribution between the centre and the periphery of the lesion (Figures 3 and 4). Probably these perfusion
patterns were related to the different number, and not to the homogeneous distribution, of tumoral vessels in the
centre and in the periphery of the meningioma. The neoangiogenic vessels are also characterized by different
permeability levels. In our experience we found a strong association between PS values and
immunohistochemical endothelial markers. PS values showed a significant statistically positive correlation with
CD-34 expression and tumour aggressiveness and grade.
Figure 3.
Different cerebral blood volume (CBV) patterns in three different cases of
meningioma: (a) CBV values are similar in the whole right pterion
meningioma of a 55-year-old female; (b) higher CBV values are visible in
the central part of a tuberculum sellae ...
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Figure 4.
Meningioma permeability surface-area (PS) product patterns in three
different cases: (a) PS values are similar in the whole left frontal convexity
meningioma of a 52-year-old female; (b) higher PS values are visible in
the central part of a ethmoidal ...
The positive correlation between the PCT parameters and the immunohistochemical markers of neo-
angiogenesis, supports the usefulness of PCT values for the pre-surgical evaluation of the meningioma grading.
In a presumed high-grade meningioma, a more extensive resection is warranted; furthermore, the use of
fractionated radiotherapy or stereotactic single-dose radiosurgery could be necessary for meningiomas that are
incompletely resected, recurrent, or atypical or anaplastic.  PCT data moreover could be useful to manage
patients with small size, incidentally-found meningiomas, to better assess the biological behaviour of the tumour
and to postpone the neurosurgical treatment in selected cases.
PCT presents advantages compared with MR perfusion technique the most important being its linear signal
intensity change in response to the tissue concentration of the contrast agent.  Furthermore, it offers multiple
perfusion parameters that can be obtained with a single acquisition.
Limitations of PCT are the radiation dose to the patient and difficulties during the osseous segmentation in
diffusely calcified meningioma, in which CBV and PS are not calculable, and in skull base meningioma.
Conclusion
PCT can provide good information on meningiomas neoangiogenesis before surgery. This technique could be
complementary to the conventional magnetic resonance imaging for the differentiation between
atypical/malignant meningiomas from lower grade lesions, allowing a better management of surgery and post-
operative therapies.
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